Abstract
A prospective study of hepatitis in over two-thirds of the dialysis units in the United Kingdom has continued since 1968. After the introduction of a control and preventive programme in 1970 there was a sustained decline in the incidence of hepatitis B to the low level of 0-3% among patients and 0-1% among staff in 1973--a greater than tenfold decrease in four years. Comparisons with data from other countries suggest that the almost complete elimination of hepatitis B from dialysis units in the UK was due to the preventive programme.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Desmyter J., Bradburne A. F., Vermylen C., Daneels R., Boelaert J. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Lancet. 1975 Aug 30;2(7931):376–377. [PubMed] [Google Scholar]
- Eastwood J. B., Curtis J. R., Wing A. J., de Wardener H. E. Hepatitis in a maintenance hemodialysis unit. Ann Intern Med. 1968 Jul;69(1):59–66. doi: 10.7326/0003-4819-69-1-59. [DOI] [PubMed] [Google Scholar]
- Surgenor D. M., Chalmers T. C., Conrad M. E., Friedewald W. T., Grady G. F., Hamilton M., Mosley J. W., Prince A. M., Stengle J. M. Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute. N Engl J Med. 1975 Nov 20;293(21):1060–1062. doi: 10.1056/NEJM197511202932102. [DOI] [PubMed] [Google Scholar]